Mr D A Prasanna, the new chairman of ACRO India
Mr D A Prasanna is also the founder and chairman of Ecron Acunova, a CRO, and who played a major role in bringing advanced cell therapy drugs to generic drugs to Indian and global patients.
He now replaces the existing chairman Mr Apurva Shah, GMD, Veeda Clinical Research.
Speaking on the occasion, Mr Prasanna said, "Clinical research in India has contributed to bringing vaccines, drugs, devices to needy patients at affordable prices. From neglected diseases like Kala Azar to tropical disease like Malaria, Indian clinical research has alleviated suffering."
He further added that India has made a name in the world in lowering health care costs through generics and building a reputation in development of biotech drugs and medical devices.
"In the last few years, clinical research has come under criticism as being unsafe and severe regulation has been imposed," he opined.